CEO Buys 100k CEL‑SCI Shares at $1.19, Signals Confidence Amid Weak Fundamentals
CEO’s $1.19 buy of 100k CEL‑SCI shares signals potential upside amid partnership with Multikine, but weak fundamentals and a negative P/E warn investors to scrutinize carefully.
3 minutes to read